摘要
目的观察复方活血明目汤对玻璃体积血早期患者的临床疗效。方法对70例诊断为玻璃体积血的病人随机分成治疗组与对照组,每组各35例;治疗组采用复方活血明目汤治疗,对照组采用和血明目片治疗;治疗1个月后统计分析患者的临床疗效。结果两组患者的性别、年龄、眼别等一般性临床资料对比,均无统计学意义(P>0.05)。治疗1个月后,比较两组临床总有效率,治疗组与对照组分别占88.7%、68.6%,治疗组临床疗效优于对照组,差异有统计学意义(P<0.05)。结论复方活血明目汤治疗玻璃体积血早期具有较好的临床效果。
OBJECTIVE To observe the clinical effect of the Huoxue Mingmu decoction on early vitreous hemorrhage. METHODS Seventy patients with vitreous hemorrhage were randomly divided into two groups: treatment group and control group, with 35 patients in each group. Treatment group were treated by Huoxue Mingmu decoction and the control group were treated by Hexue Mingmu tablets. After 1 course of treatment, the clinical efficacy was statistically analyzed.RESULTS There were no significant difference between the two groups of patients in terms of gender, age, and other general clinical data(P>0.05). After 1 course of treatment, the total effective rate of the two groups were 88.7% and 68.6% respectively. Effective scores of treatment group was better than it of control group and the difference was of statistical difference(P<0.05). CONCLUSIONS Huoxue Mingmu decoction was effective in treatment of vitreous hemorrhage in early stage.
作者
马朝廷
杨迎新
马秋艳
张丹丹
赵彦萍
李喜文
MA Chaoting;YANG Yingxin;MA Qiuyan(Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China)
出处
《中国中医眼科杂志》
2019年第2期134-136,共3页
China Journal of Chinese Ophthalmology
基金
国家中医药管理局国家中医临床研究基地业务建设科研专项(JDZX2015283)
关键词
复方活血明目汤
玻璃体积血
临床疗效
Huoxue Mingmu decoction
vitreous hemorrhage
clinical effect
